Drug company pays $95 million to settle marketing suit
Germany-based pharmaceutical maker Boehringer Ingelheim Pharmaceuticals has settled a suit against it brought by the U.S. Department of Justice, which accused the company of marketing some of its drugs for unapproved uses.
By Cathleen Flahardy|October 26, 2012
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.